|
1.
|
Roger VL, Go AS, Lloyd-Jones DM, et al:
Heart disease and stroke statistics - 2011 update: a report from
the American Heart Association. Circulation. 123:e18–e209. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Roger VL, Go AS, Lloyd-Jones DM, et al:
Heart disease and stroke statistics - 2012 update: a report from
the American Heart Association. Circulation. 125:e2–e220. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Goldstein JL and Brown MS: Regulation of
the mevalonate pathway. Nature. 343:425–430. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Wang LJ and Song BL: Niemann-Pick C1-Like
1 and cholesterol uptake. Biochim Biophys Acta. 1821:964–972. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Altmann SW, Davis HR Jr, Zhu LJ, et al:
Niemann-Pick C1 Like 1 protein is critical for intestinal
cholesterol absorption. Science. 303:1201–1204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Betters JL and Yu L: NPC1L1 and
cholesterol transport. FEBS Lett. 584:2740–2747. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Jia L, Betters JL and Yu L: Niemann-pick
C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol
transport. Annu Rev Physiol. 73:239–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Suchy D, Labuzek K, Stadnicki A and
Okopien B: Ezetimibe - a new approach in hypercholesterolemia
management. Pharmacol Rep. 63:1335–1348. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Xie C, Zhou ZS, Li N, et al: Ezetimibe
blocks the internalization of NPC1L1 and cholesterol in mouse small
intestine. J Lipid Res. 2092–2101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Yu L, Bharadwaj S, Brown JM, et al:
Cholesterol-regulated translocation of NPC1L1 to the cell surface
facilitates free cholesterol uptake. J Biol Chem. 281:6616–6624.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Sainz B Jr, Barretto N, Martin DN, et al:
Identification of the Niemann-Pick C1-like 1 cholesterol absorption
receptor as a new hepatitis C virus entry factor. Nat Med.
18:281–285. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Simon JS, Karnoub MC, Devlin DJ, et al:
Sequence variation in NPC1L1 and association with improved
LDL-cholesterol lowering in response to ezetimibe treatment.
Genomics. 86:648–656. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Wang J, Williams CM and Hegele RA:
Compound heterozygosity for two non-synonymous polymorphisms in
NPC1L1 in a non-responder to ezetimibe. Clin Genet. 67:175–177.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Livak KJ: Allelic discrimination using
fluorogenic probes and the 5′ nuclease assay. Genet Anal.
14:143–149. 1999.
|
|
15.
|
Ray K: Hepatitis: NPC1L1 identified as a
novel HCV entry factor. Nat Rev Gastroenterol Hepatol. 9:1242012.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Wang LJ, Wang J, Li N, Ge L, Li BL and
Song BL: Molecular characterization of the NPC1L1 variants
identified from cholesterol low absorbers. J Biol Chem.
286:7397–7408. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Polisecki E, Peter I, Simon JS, et al:
Genetic variation at the NPC1L1 gene locus, plasma lipoproteins,
and heart disease risk in the elderly. J Lipid Res. 51:1201–1207.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Cohen JC, Pertsemlidis A, Fahmi S, et al:
Multiple rare variants in NPC1L1 associated with reduced sterol
absorption and plasma low-density lipoprotein levels. Proc Natl
Acad Sci USA. 103:1810–1815. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Fahmi S, Yang C, Esmail S, Hobbs HH and
Cohen JC: Functional characterization of genetic variants in NPC1L1
supports the sequencing extremes strategy to identify complex trait
genes. Hum Mol Genet. 17:2101–2107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Maeda T, Honda A, Ishikawa T, et al: A SNP
of NPC1L1 affects cholesterol absorption in Japanese. J Atheroscler
Thromb. 17:356–360. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Hegele RA, Guy J, Ban MR and Wang J:
NPC1L1 haplotype is associated with inter-individual variation in
plasma low-density lipoprotein response to ezetimibe. Lipids Health
Dis. 4:162005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Chen CW, Hwang JJ, Tsai CT, et al: The
g.-762T>C polymorphism of the NPC1L1 gene is common in Chinese
and contributes to a higher promoter activity and higher serum
cholesterol levels. J Hum Genet. 54:242–247. 2009.
|
|
23.
|
Teslovich TM, Musunuru K, Smith AV, et al:
Biological, clinical and population relevance of 95 loci for blood
lipids. Nature. 466:707–713. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Zhao HL, Houweling AH, Vanstone CA, et al:
Genetic variation in ABC G5/G8 and NPC1L1 impact cholesterol
response to plant sterols in hypercholesterolemic men. Lipids.
43:1155–1164. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Lomer MC: Dietary and nutritional
considerations for inflammatory bowel disease. Proc Nutr Soc.
70:329–335. 2011. View Article : Google Scholar : PubMed/NCBI
|
